Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

NCT02761057 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

NIH

Sponsor class

Conditions

Locally Advanced Papillary Renal Cell Carcinoma
Metastatic Papillary Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v7
Stage IV Renal Cell Cancer AJCC v7
Type 1 Papillary Renal Cell Carcinoma
Type 2 Papillary Renal Cell Carcinoma
Unresectable Renal Cell Carcinoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
DRUG: Cabozantinib S-malate
PROCEDURE: Computed Tomography
DRUG: Crizotinib
DRUG: Savolitinib
DRUG: Sunitinib Malate

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]